Search
forResearch 10 of 1000+
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- P151 A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: patient-reported outcome measures
- PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Evaluating the accuracy of patient-reported hair outcomes versus trichometric measurements in PRP therapy
- Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
- A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders
Learn 4 of 21
All learn results →Community
— no results
Try a deeper search in community →